Detected ·

201 Therapeutics

——

201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).

Website
—
Amount
—
Stage
—
Event
Funding round
Detected
2026-05-27 08:04:47 UTC
Signal ID
62d704af-4af5-4241-80b3-75f170326b5a

As the API returns it

{
  "id": "62d704af-4af5-4241-80b3-75f170326b5a",
  "created_at": "2026-05-27T08:04:47.615664Z",
  "company_name": "201 Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": "https://www.linkedin.com/company/201-therapeutics",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).*"
}

Latest rounds